Jordi Castellsague

Summary

Affiliation: RTI International
Country: USA

Publications

  1. doi request reprint Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs
    Jordi Castellsague
    Pfizer Global Epidemiology, Safety, and Risk Management, Barcelona, Spain
    Pharmacotherapy 29:1397-407. 2009
  2. doi request reprint Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy
    Jordi Castellsague
    RTI Health Solutions, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 22:365-75. 2013
  3. pmc Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)
    Jordi Castellsague
    RTI Health Solutions, Barcelona, Spain
    Drug Saf 35:1127-46. 2012
  4. doi request reprint The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada
    Cristina Varas-Lorenzo
    Pfizer, Global Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 18:1016-25. 2009
  5. doi request reprint Clinical burden and incremental cost of fractures in postmenopausal women in the United Kingdom
    Lia Gutiérrez
    RTI Health Solutions, Trav Gracia 56 Atico 1, 08006 Barcelona, Spain
    Bone 51:324-31. 2012
  6. ncbi request reprint Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports
    David Sanchez-Matienzo
    Global Epidemiology, Safety and Risk Management, Pfizer Worldwide Development, Pl Xavier Cugat 2, D 08174 Sant Cugat del Vallès, Barcelona, Spain
    Clin Ther 28:1123-32. 2006
  7. ncbi request reprint Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level
    Cristina Varas-Lorenzo
    Global Epidemiology, Safety and Risk Management, Pfizer Worldwide Development, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 16:366-76. 2007
  8. doi request reprint Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database
    Cristina Varas-Lorenzo
    RTI Health Solutions, Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 17:842-52. 2008
  9. doi request reprint Stroke risk and NSAIDs: a systematic review of observational studies
    Cristina Varas-Lorenzo
    RTI Health Solutions, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 20:1225-36. 2011
  10. doi request reprint Use of long-acting beta-agonists and inhaled steroids in asthma: meta-analysis of observational studies
    Ceri Hirst
    Department of Epidemiology, RTI Health Solutions, Barcelona, Spain
    J Asthma 47:439-46. 2010

Collaborators

Detail Information

Publications12

  1. doi request reprint Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs
    Jordi Castellsague
    Pfizer Global Epidemiology, Safety, and Risk Management, Barcelona, Spain
    Pharmacotherapy 29:1397-407. 2009
    ....
  2. doi request reprint Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy
    Jordi Castellsague
    RTI Health Solutions, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 22:365-75. 2013
    ..In the context of the European regulatory review on nimesulide, we estimated and compared the risk associated with nimesulide and other individual NSAIDs with the risk in nonusers...
  3. pmc Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)
    Jordi Castellsague
    RTI Health Solutions, Barcelona, Spain
    Drug Saf 35:1127-46. 2012
    ....
  4. doi request reprint The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada
    Cristina Varas-Lorenzo
    Pfizer, Global Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 18:1016-25. 2009
    ....
  5. doi request reprint Clinical burden and incremental cost of fractures in postmenopausal women in the United Kingdom
    Lia Gutiérrez
    RTI Health Solutions, Trav Gracia 56 Atico 1, 08006 Barcelona, Spain
    Bone 51:324-31. 2012
    ..In this study, hospitalizations were the main driver of the overall incremental cost during the 12months following the fracture. Mortality in women in the selected fracture cohorts was higher than in women in the non-fracture cohorts...
  6. ncbi request reprint Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports
    David Sanchez-Matienzo
    Global Epidemiology, Safety and Risk Management, Pfizer Worldwide Development, Pl Xavier Cugat 2, D 08174 Sant Cugat del Vallès, Barcelona, Spain
    Clin Ther 28:1123-32. 2006
    ..Hepatic adverse events associated with the use of nonaspirin drugs and NSAIDs are uncommon, but the widespread use of these drugs may impact public health...
  7. ncbi request reprint Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level
    Cristina Varas-Lorenzo
    Global Epidemiology, Safety and Risk Management, Pfizer Worldwide Development, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 16:366-76. 2007
    ....
  8. doi request reprint Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database
    Cristina Varas-Lorenzo
    RTI Health Solutions, Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 17:842-52. 2008
    ..Case definitions are essential to epidemiological research...
  9. doi request reprint Stroke risk and NSAIDs: a systematic review of observational studies
    Cristina Varas-Lorenzo
    RTI Health Solutions, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 20:1225-36. 2011
    ..To perform a quantitative systematic review of observational studies on the risk of stroke associated with the use of individual NSAIDs...
  10. doi request reprint Use of long-acting beta-agonists and inhaled steroids in asthma: meta-analysis of observational studies
    Ceri Hirst
    Department of Epidemiology, RTI Health Solutions, Barcelona, Spain
    J Asthma 47:439-46. 2010
    ..Data on the risk of asthma exacerbations of LABAs in combination with ICSs, as prescribed in typical clinical practice, are very scarce...
  11. doi request reprint Study of the incremental cost and clinical burden of hip fractures in postmenopausal women in the United Kingdom
    Lia Gutiérrez
    RTI Health Solutions, Spain
    J Med Econ 14:99-107. 2011
    ..To determine the incremental cost of healthcare and clinical outcomes in the 12 months following incident hip fractures among postmenopausal women in the UK...
  12. ncbi request reprint Use of oral corticosteroids and the risk of acute myocardial infarction
    Cristina Varas-Lorenzo
    Pfizer Worldwide Development, Global Epidemiology, Sant Cugat del Vallès, Barcelona, Spain
    Atherosclerosis 192:376-83. 2007
    ..A few epidemiological studies suggested an increased coronary heart disease (CHD) risk with high doses of oral corticosteroids...